Genesis Cancer and Blood Institute

Name

Genesis Cancer and Blood Institute

Legal name

Genesis Cancer and Blood Institute

Website

https://genesiscancerblood.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Community Oncology and Hematology Care

NAICS

Offices of Physicians (62111), Blood and Organ Banks (621991), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industries

Hematologic Oncology (Leukemia/Lymphoma/Myeloma) (HLAKAFAD), Hematology & Coagulation Laboratories (HLAFAMAC), Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH), Oncology & Hematology Pharmaceuticals (HLAIAAAC), Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL)

Keywords

• Community oncology services
• Hematology care
• Cancer treatment
• Infusion therapy
• Clinical trials oncology

Headquarters

HQ city

Hot Springs Village

HQ country

United States

HQ region

North America

Offices11 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Patient Care Services: Fee-for-service healthcare revenue from medical oncology, hematology, endocrinology, and related clinical services. Revenue generated through insurance reimbursement from Medicare, Medicaid, and private insurers. Includes infusion therapy, diagnostic imaging, pathology, pharmacy, and telehealth services.
2. Specialty Pharmacy Services: In-house specialty pharmacy providing oral cancer medications with efficient home delivery and insurance coordination services.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Genesis Cancer and Blood Institute is a community-based medical oncology and hematology practice delivering comprehensive cancer and blood disorder care across 11 Arkansas locations. The practice provides chemotherapy, immunotherapy, targeted therapy, BiTE therapy, radioligand therapy, diagnostic imaging, in-house pathology and specialty pharmacy services, plus clinical trials, genetic testing, telehealth, and care coordination for patients diagnosed with all types of cancer and hematologic conditions.

Product overview

Genesis Cancer and Blood Institute is a community-based medical oncology and hematology practice providing comprehensive cancer care through integrated services. The practice operates as a single unified care model offering 14 distinct service lines: Medical Oncology and Hematology as core treatment services, supplemented by Endocrinology, BiTE Therapy, Radioligand Therapy, Diagnostic Imaging, and Pathology for diagnostics and advanced treatments; Pharmacy for in-house specialty medications; Care Coordination & Navigation, Patient Advocacy, Financial Support, and Telehealth for patient support; and Clinical Trials and Genetic Testing for research and risk assessment. All services are delivered across 11 locations in Arkansas with the mission of providing care close to home.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Oncology Medical oncology service using chemotherapy, biological agents, targeted therapies, immunotherapy, and oral chemotherapy medications to treat patients with all types of cancer, delivered across 11 Arkansas clinic locations.
• Hematology Hematology service treating patients with all types of hematologic malignancies, including rare blood-based liquid tumors and autoimmune abnormalities, with integrated blood banking and clotting abnormality management.
• Endocrinology Comprehensive endocrinology services covering a wide range of hormonal and metabolic conditions including diabetes management, integrated with the practice's oncology service line.
• BiTE Therapy Bispecific T-cell Engager (BiTE) therapy that links T cells to cancer cells to boost immune response with precision and fewer side effects than traditional treatments.
• Diagnostic Imaging Advanced diagnostic imaging service providing precise views of internal organs, bones, soft tissues, and blood vessels with next-generation imaging technologies.
• Radioligand Therapy Radioligand therapy (RLT) that delivers radiation directly to cancer cells, reducing exposure to healthy tissue and minimizing side effects.
• Pathology Centralized laboratory and pathology services for routine and specialized laboratory testing, reducing patient trips to multiple locations.
• Pharmacy In-house specialty pharmacy services providing oral oncolytic medications with experienced staff, seamless insurance coordination, and efficient home delivery.
• Care Coordination & Navigation Care coordination and navigation service that helps patients successfully navigate the cancer treatment process through team support, symptom management, nutrition counseling, and overall wellbeing assistance.
• Patient Advocacy Patient advocacy service guiding patients through and around barriers in the complex cancer care system from diagnosis to survivorship or end of life.
• Clinical Trials Clinical trial service enabling patients to participate in approved and exploratory therapies without long-distance travel through partnerships with Sarah Cannon Research Institute.
• Genetic Testing Genetic cancer risk assessment service focused on identifying inherited risk for certain types of cancer.
• Financial Support Financial counseling service helping patients navigate insurance coverage, access financial assistance programs, and manage treatment costs.
• Telehealth Telehealth service providing virtual video visits with physicians, practitioners, nurses, or dietitians via secure video chat from home or any private location.

Quantifiable outcome

• COA study shows community oncology delivers high-quality outcomes: 48 months median survival vs 40 months benchmark for metastatic breast cancer; 15 months vs 13 months for metastatic NSCLC

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered major, core and supporting.

• CanCare, Inc.majorStrategic or Co-development Partner · 11 June 2026Partnership announced June 2026 during National Cancer Survivors Month. CanCare connects cancer patients with trained volunteer survivors and caregivers for free emotional support. Builds on successful pilot programs at four AON partner practices. Services available at all stages of cancer journey including newly diagnosed, undergoing treatment, and survivorship.
• Colla HealthmajorStrategic or Co-development Partner · 10 June 2026National partnership launched June 2026 to expand access to behavioral health services for cancer patients. Partnership launches at AON partner practices including Genesis Cancer and Blood Institute and Hematology Oncology of Indiana. Provides specialized behavioral health support including therapeutic support, case management, and psychiatric consultation designed specifically for people living with cancer through telehealth and phone-based services.
• Sarah Cannon Research InstitutecoreStrategic or Co-development Partner · 22 September 2021Partnership announced September 2021 to expand patient access to community-based clinical research. Sarah Cannon is a global leader in offering community-based clinical trials with over 500 first-in-human clinical trials led since 1993. Provides patients access to expanded menu of clinical trials in the community setting.
• American Oncology Network (AON)coreStrategic or Co-development Partner · 1 January 2018Genesis Cancer and Blood Institute is a partner practice of American Oncology Network, joining in 2018. AON is an alliance of physicians and healthcare leaders supporting community oncology. Partnership provides access to centralized specialty pharmacy, diagnostics, pathology, integrated EMR, care management team, financial assistance programs, and practice management expertise. AON represents 350+ providers across 21 states.
• Our Promise Cancer ResourcemajorStrategic or Co-development PartnerLocal nonprofit organization dedicated to helping patients navigate financial and practical challenges of cancer treatment. Created by Genesis over 10 years ago with $1.2 million donated to help ease patient expenses. Provides direct financial assistance, transportation support, temporary housing for traveling patients, basic living needs assistance, and community-based support and education initiatives.
• Meaningful Insights Biotech Analytics (MiBA)supportingTechnology or IntegrationAON informatics venture in partnership with Ascend Technologies Group. Dr. Jim Chen serves as developer integrating AI solutions into clinical medicine to advance personalized medicine through clinical decision support, data analytics, and clinical trial matching.

Scale indicators6 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• Tennessee Oncology: Large community oncology practice operating multi-location clinics across Tennessee with similar in-house pharmacy, imaging, and clinical trial offerings; serves as a comparable scale benchmark for a multi-clinic community oncology model.
• Virginia Cancer Specialists: Multi-site community oncology and hematology practice serving the D.C. metro with integrated diagnostic and treatment services; same specialty outpatient oncology service mix.
• Florida Oncology / Heme Onc Care: Multi-site community oncology and hematology practice offering integrated infusion, imaging, and lab services in Florida; comparable in service breadth and patient-acquisition model.
• Illinois Cancer Specialists: Community-based medical oncology practice with multiple suburban Chicago locations, infusion services, and clinical trial participation; directly mirrors Genesis's regional-clinic, in-house pharmacy model.
• Minnesota Oncology: Large community-based medical oncology practice with locations across the Twin Cities metro offering infusion, imaging, lab, and clinical trials; comparable scale and integrated service delivery.
• Hematology Oncology of Indiana: AON partner community oncology practice operating multiple Indianapolis-area locations; chosen as a peer because it is explicitly identified alongside Genesis as an AON launch site for the Colla Health behavioral health partnership, making it the closest comparable AON-affiliated practice.
• Willamette Valley Cancer Institute: Community oncology practice in Oregon offering medical oncology, hematology, radiation oncology, and clinical trials across multiple satellite clinics; similar multi-site, service-breadth model.

Broad incumbents

• US Oncology Network (McKesson): Large national network of community oncology practices backed by McKesson, offering similar in-house pharmacy, infusion, and clinical trial capabilities; comparable broad incumbent platform.
• American Oncology Network (AON): Parent alliance of community oncology practices with 350+ providers across 21 states; Genesis is an AON partner, so AON functions as a peer and platform comparable to community-oncology MSO-type players such as OneOncology and US Oncology.
• OneOncology: Platform partnership that provides management, technology, and growth capital to independent community oncology practices; a direct competitive platform to AON with overlapping partner-practice model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/GenesisCancer
• LinkedInlinkedin.com/company/genesis-cancer-ctr

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genesis Cancer and Blood Institute